Early Clinical Outcomes After Mitral Valve Repair Versus Replacement Combined With Coronary Artery Bypass Grafting in Patients With Ischemic Mitral Regurgitation
DOI:
https://doi.org/10.64149/Keywords:
Ischemic Mitral Regurgitation; Mitral Valve Repair; Mitral Valve Replacement; Coronary Artery Bypass Grafting; Cardiopulmonary Bypass.Abstract
Background: Ischemic mitral regurgitation (IMR) is linked to poor left ventricular remodeling and worse long-term outcomes, and it commonly exacerbates coronary artery disease.
Aim: To compare the early postoperative outcomes of mitral valve repair versus replacement combined with coronary artery bypass grafting (CABG) in patients with ischemic mitral regurgitation.
Patients and Methods: This prospective comparative study included 80 patients with ischemic mitral regurgitation undergoing CABG at Al-Ahrar Teaching Hospital and National Heart Institute. Patients were equally assigned to mitral valve repair with ring annuloplasty (Group I, n = 40) or mitral valve replacement with a mechanical or bioprosthetic valve (Group II, n = 40), both combined with CABG. Baseline characteristics, preoperative findings, intraoperative variables, postoperative course and complications, and discharge echocardiographic outcomes were compared between groups.
Results: The replacement group had significantly longer aortic cross-clamp time (86.1 ± 18.7 vs. 69.2 ± 15.4 min, P = 0.001) and a longer ICU stay [median 3 days (range 2–7) vs. 3 days (range 1–5), P = 0.046], with a trend toward longer cardiopulmonary bypass time (P = 0.06). Other postoperative outcomes, including ventilation time, hospital stay, inotrope or IABP use, complications, and 30-day mortality (2.5% in each group), were comparable. Discharge LVEF was also similar (P = 0.744), whereas the median residual MR grade was significantly lower after replacement.
Conclusion: Mitral valve repair and replacement showed similar 30-day mortality and surgical morbidity in patients with ischemic mitral regurgitation undergoing concomitant CABG. Replacement was associated with longer ICU and cross-clamp times but provided more reliable early correction of MR, whereas repair had shorter operative courses but a higher rate of residual moderate-to-severe MR. The choice should therefore be individualized based on valve morphology, subvalvular pathology, and operative risk.



